Biology of Arterial Atheroma
暂无分享,去创建一个
[1] P. Libby. Molecular bases of the acute coronary syndromes. , 1995, Circulation.
[2] G. Gibbons,et al. The emerging concept of vascular remodeling. , 1994, The New England journal of medicine.
[3] V. Fuster,et al. Coronary atherosclerosis : a multifactorial disease , 1993 .
[4] P. Barter,et al. High-density lipoproteins and coronary heart disease. , 1991, Journal of cardiovascular risk.
[5] W. Poewe,et al. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. , 1997, Circulation.
[6] W. Poewe,et al. Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease. , 1999, Circulation.
[7] P. Libby,et al. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[8] C. Zarins,et al. Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.
[9] V. Fuster,et al. Coronary plaque disruption. , 1995, Circulation.
[10] S. Kiechl,et al. Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[11] M J Davies,et al. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. , 1996, Circulation.
[12] Qingbo Xu,et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis : clinical significance determined in a follow-up study. , 1999, Circulation.
[13] S. Moore,et al. Pathogenesis of atherosclerosis. , 1985, Metabolism: clinical and experimental.
[14] R. Virmani,et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. , 1997, The New England journal of medicine.
[15] K. Borch-Johnsen,et al. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. , 1995, Clinical science.
[16] J. Freyssinet,et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. , 1999, Circulation.
[17] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[18] C. Warlow,et al. Evidence of a chronic systemic cause of instability of atherosclerotic plaques , 2000, The Lancet.
[19] S. Kiechl,et al. The natural course of atherosclerosis. Part I: incidence and progression. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[20] D. Celermajer,et al. Endothelial dysfunction: does it matter? Is it reversible? , 1997, Journal of the American College of Cardiology.
[21] W. Roberts,et al. Hemodynamic shear force in rupture of coronary arterial atherosclerotic plaques. , 1990, The American journal of cardiology.
[22] F. Kronenberg,et al. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. , 1999, Circulation.
[23] V. Fuster,et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. , 1997, Circulation.
[24] R. Ross,et al. The pathogenesis of atherosclerosis (first of two parts). , 1976, The New England journal of medicine.
[25] S. Kiechl,et al. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. , 1999, Journal of the American College of Cardiology.
[26] S. Kiechl,et al. Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[27] J L Witztum,et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.
[28] M J Davies,et al. Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. , 1985, British heart journal.
[29] D. Steinberg,et al. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[30] G. Gibbons. Endothelial function as a determinant of vascular function and structure: a new therapeutic target. , 1997, The American journal of cardiology.
[31] S. Kiechl,et al. The natural course of atherosclerosis. Part II: vascular remodeling. Bruneck Study Group. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[32] W. B. Robertson,et al. Mechanical factors in atherosclerosis. , 1957, Lancet.
[33] V. Fuster,et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. , 1994, Journal of the American College of Cardiology.
[34] V. Fuster,et al. Macrophage Infiltration in Acute Coronary Syndromes: Implications for Plaque Rupture , 1994, Circulation.
[35] A H Davies,et al. The symptomatic carotid plaque. , 2000, Stroke.
[36] L. A. Miasnikov,et al. [Estrogens and atherosclerosis]. , 1965, Kardiologiia.
[37] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.
[38] P. Libby,et al. Apoptosis of Vascular Smooth Muscle Cells Induced by In Vitro Stimulation With Interferon-γ, Tumor Necrosis Factor–α, and Interleukin-1β , 1996 .
[39] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). , 1992, The New England journal of medicine.
[40] P. Ridker,et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.
[41] R. Kamm,et al. Distribution of Circumferential Stress in Ruptured and Stable Atherosclerotic Lesions A Structural Analysis With Histopathological Correlation , 1993, Circulation.